- Home
- STEM vs CNTX Comparison
STEM vs CNTX Comparison
Compare STEM & CNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STEM
- CNTX
- Stock Information
- Founded
- STEM 2009
- CNTX 2015
- Country
- STEM United States
- CNTX United States
- Employees
- STEM N/A
- CNTX N/A
- Industry
- STEM Computer Software: Prepackaged Software
- CNTX Biotechnology: Pharmaceutical Preparations
- Sector
- STEM Technology
- CNTX Health Care
- Exchange
- STEM Nasdaq
- CNTX Nasdaq
- Market Cap
- STEM 72.0M
- CNTX 60.7M
- IPO Year
- STEM N/A
- CNTX 2021
- Fundamental
- Price
- STEM $0.34
- CNTX $0.55
- Analyst Decision
- STEM Hold
- CNTX Strong Buy
- Analyst Count
- STEM 9
- CNTX 5
- Target Price
- STEM $1.11
- CNTX $6.50
- AVG Volume (30 Days)
- STEM 3.4M
- CNTX 83.5K
- Earning Date
- STEM 03-04-2025
- CNTX 05-07-2025
- Dividend Yield
- STEM N/A
- CNTX N/A
- EPS Growth
- STEM N/A
- CNTX N/A
- EPS
- STEM N/A
- CNTX N/A
- Revenue
- STEM $144,584,000.00
- CNTX N/A
- Revenue This Year
- STEM $125.17
- CNTX N/A
- Revenue Next Year
- STEM $22.49
- CNTX N/A
- P/E Ratio
- STEM N/A
- CNTX N/A
- Revenue Growth
- STEM N/A
- CNTX N/A
- 52 Week Low
- STEM $0.30
- CNTX $0.55
- 52 Week High
- STEM $2.21
- CNTX $2.75
- Technical
- Relative Strength Index (RSI)
- STEM 36.67
- CNTX 32.80
- Support Level
- STEM $0.41
- CNTX $0.64
- Resistance Level
- STEM $0.39
- CNTX $0.99
- Average True Range (ATR)
- STEM 0.04
- CNTX 0.10
- MACD
- STEM -0.00
- CNTX -0.02
- Stochastic Oscillator
- STEM 0.07
- CNTX 0.02
About STEM Stem Inc.
Stem Inc is a provider of energy storage systems. The company bundles third-party hardware with its proprietary Athena software to provide customers a turnkey solution. Stem sells its solutions to commercial and industrial customers as well as independent power producers and renewable developers. Its solutions help customers maximize renewable energy generation and help build a cleaner and more resilient grid. The Company operates as one operating segment that is focused exclusively on technology services that transform the way energy is distributed and consumed.
About CNTX Context Therapeutics Inc.
Context Therapeutics Inc is a clinical-stage biopharmaceutical company advancing medicines for solid tumors. The development team is advancing a pipeline of innovative therapies with a primary focus on treating female, hormone-dependent cancer, including breast, ovarian, and endometrial cancer. The company's preclinical program, CTIM-76, is an anti-Claudin 6 ("CLDN6") x anti-CD3 bispecific antibody ("bsAb") that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.